DeSimone John 4

What Happened

• John DeSimone, Chief Financial Officer of Herbalife Ltd. (HLF), was granted 45,195 stock appreciation rights (SARs) on February 25, 2026. The Form 4 records the acquisition price as $0.00 and the transaction is reported as an award/acquisition (code A). This is a derivative award, not an open-market purchase or sale of common stock.

Key Details

• Transaction date: 2026-02-25; Filing date: 2026-02-27 (appears timely within the standard two-business-day Form 4 window).
• Amount granted: 45,195 SARs; Per-share price recorded: $0.00; total recorded cash consideration: $0.
• Shares owned after transaction: Not specified in the provided excerpt of the filing.
• Footnote: These are SARs granted under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan. They vest in one-third increments on Feb 25 of 2027, 2028 and 2029, subject to continued service (per filing footnote).
• Transaction code: A = Award/Grant (derivative instrument).

Context

• Stock Appreciation Rights (SARs) give the holder the right to receive the appreciation in Herbalife’s stock price (typically in cash or stock) and do not represent immediate ownership of shares. This grant is a form of compensation/retention rather than a market buy or sell; it does not by itself indicate insider buying or selling sentiment.